Skip to main content

How do Ozempic and Metformin compare for diabetes?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on Sep 8, 2025.

Official Answer by Drugs.com

Key Points

Who Can Use Metformin and Ozempic?

Both Ozempic (semaglutide) and metformin serve as type 2 diabetes medications, but approved ages and suitability differ. Metformin is the only oral antihyperglycemic drug with FDA approval for children as young as age 10. Ozempic’s use is limited to adults aged 18 and older due to a lack of pediatric clinical trial data and safety concerns in younger patients.

Metformin is FDA approved to treat type 2 diabetes in people 10 years and older, while Ozempic has a few other indications. Specifically, Ozempic is approved for:

Mechanism of Action: How Ozempic and Metformin Work Differently

Ozempic (semaglutide) and metformin both help manage blood sugar levels but work in different ways:

Metformin

Metformin is a biguanide that is taken by mouth up to a few times daily. It works in different ways to manage blood glucose levels:

Ozempic

Ozempic (semaglutide) is an injectable GLP-1 receptor agonist, meaning it mimics a naturally occurring hormone in your body called glucagon-like peptide-1. It is injected under the skin once a week. It works by:

How Effective Are Metformin and Ozempic?

Though no direct comparison studies for type 2 diabetes exist, separate trials show both medications effectively lower hemoglobin A1C (HbA1c) levels:

Individual responses vary based on dose, lifestyle, and concurrent medications.

Comparing Weight Loss: What Clinical Studies Show

Neither Ozempic nor metformin are FDA-approved for weight loss, but both have been associated with modest weight reduction. Ozempic and metformin can support weight loss, but studies show Ozempic generally leads to more significant results.

Metformin and Weight Loss

Experts classify metformin as a weight-neutral treatment option for patients with type 2 diabetes. It has the potential to cause a small amount of weight loss in some patients.

Ozempic and Weight Loss

Because Ozempic slows down how fast food moves through your digestive tract, it can decrease your appetite and result in lower calorie consumption. This can lead to weight loss in some patients.

In a 30-week study:

In major trials, people taking Ozempic together with diet and exercise lost an average of 14.9–17.4% of their body weight over 68 weeks—far exceeding typical results with metformin alone, which often yield more modest weight reductions.

Weight loss with Ozempic is seen in people with type 2 diabetes, as well as those without diabetes but who are overweight or obese. In contrast, metformin tends to have mild-to-moderate effects on weight, with greatest benefit among those with insulin resistance or polycystic ovary syndrome (PCOS).

Patient Suitability: Which Medication for Whom?

Metformin is commonly recommended as a first-line therapy for most adults newly diagnosed with type 2 diabetes, thanks to its long track record, safety profile, low risk of causing low blood sugar, and affordability. Patients with moderate kidney disease, liver issues, or at risk for lactic acidosis may require closer monitoring or alternatives.

Ozempic is usually added when blood sugar remains high despite metformin, or for people who would benefit from greater weight loss or cardiovascular protection (such as those with existing heart disease) or kidney protection (those with chronic kidney disease). Ozempic is generally not given to people with a history of certain thyroid cancers or pancreatitis.

Related questions

Can You Take Metformin and Ozempic Together?

Yes. Studies show no interaction between the two medications. Since they work differently, they are often prescribed together for better blood sugar control. It’s becoming increasingly common to combine Ozempic with metformin, as their complementary mechanisms may deliver greater blood sugar reduction and enhanced weight loss.

Healthcare providers typically start with metformin, add Ozempic if needed, and encourage patients to maintain regular communication about side effects or changes in health status. Therapy is individualized and patients are closely monitored for gastrointestinal side effects and hypoglycemia (low blood sugar).

During clinical studies submitted to the FDA for approval, some patients with type 2 diabetes took both Ozempic and metformin. If your blood sugar is not well controlled with one medication alone, your healthcare provider may recommend adding on another medication.

Side Effects of Metformin and Ozempic

Both medications commonly cause gastrointestinal side effects. Additionally, metformin can raise the risk for lactic acidosis. Some patients have reported pancreatitis while taking Ozempic.

Common Side Effects of Metformin (>5%)

Common Side Effects of Ozempic (≥5%)

Serious Risks

Below is a comparison table of side effects typically seen with Ozempic and metformin.

Side Effect Metformin Ozempic
Nausea 26% 16-20%
Diarrhea 53% 9%
Constipation Rare 3-5%
Vomiting 26% 5-9%
Abdominal Pain 6% 6-7%

Cost Comparison and Insurance

For cost-sensitive patients, metformin is often available for as little as $4–$15/month as a generic. Ozempic, being brand-only, usually costs $850–$1,100/month without insurance, though copay assistance programs and insurance coverage can lower out-of-pocket expenses to $25–$45 monthly in some cases. The manufacturer of Ozempic is currently offering Ozempic for $499/month for certain patients without insurance. Coverage and eligibility may vary by country, insurance plan, and clinical indication.

Key Takeaways

Ozempic and metformin are both effective for type 2 diabetes, but they work differently. Metformin is usually the first-line treatment due to its long-standing safety profile and affordability, while Ozempic may be considered when additional blood sugar or weight management is needed or for patients with certain medical conditions.

This is not all the information you need to know about metformin and Ozempic for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full product information here, and discuss this information and any questions you have with your doctor or other health care provider.

References
  1. Campforts, B., Drukker, M., van Amelsvoort, T., & Bak, M. (2024). Management of obesity with semaglutide or metformin in patients with antipsychotic-induced weight gain (MOSA): a non-randomised open-label pilot study. BMC psychiatry, 24(1), 865. https://doi.org/10.1186/s12888-024-06317-7
  2. Corcoran, C., et. al. Metformin. [Updated 2023 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Accessed on September 8, 2025 at https://www.ncbi.nlm.nih.gov/books/NBK518983/
  3. Fornes, A., Huff, J., Pritchard, R. I., & Godfrey, M. (2022). Once-Weekly Semaglutide for Weight Management: A Clinical Review. The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 38(4), 239–246. https://doi.org/10.1177/87551225221092681
  4. Hausner, H., et. al. (2017). Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects. In: Clinical Pharmacokinetics. DOI: https://doi.org/10.1007%2Fs40262-017-0532-6
  5. Kahn, S. E., et. al. (2006). Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. In: The New England Journal of Medicine. DOI: https://doi.org/10.1056/nejmoa066224
  6. Metformin [package insert]. (Updated 01/2023). ScieGen Pharmaceuticals Inc. Accessed 07/04/2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e4c4ba9-65c6-4273-8f6b-2423ab521dad
  7. Novo Nordisk. (n.d.). Savings & resources. Ozempic. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
  8. Ozempic [package insert]. (Updated 09/2023). Novo Nordisk. Accessed 07/04/2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  9. Van Gaal, L., et. al. (2015). Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment. In: Diabetes Care. DOI: https://doi.org/10.2337/dc14-1630
  10. Walling, A. D. 2003. Metformin for polycystic ovary syndrome. AAFP. https://www.aafp.org/pubs/afp/issues/2003/1201/p2265a.html

Read next

Why does metformin cause diarrhea?

Metformin causes diarrhea by changing gut bacteria, affecting bile acid absorption, blocking water absorption in the intestines, and increasing gut-stimulating hormones. These combined effects make stools looser and more frequent.

Continue reading

Can you take metformin without food?

If you take metformin without food you may end up with an upset stomach, especially if you are just starting treatment. Nausea and vomiting are some of the most common side effects with metformin and can occur in over 30% of patients.

Continue reading

Does metformin lower A1C, if so how much?

When metformin is used alone as monotherapy, it lowers A1C by about 1% to 2% on average. A1C is a measure of longer-term blood sugar control. In most patients, metformin is suggested as the initial treatment for type 2 diabetes, but its glucose-lowering effect may not be adequate for all patients if used alone. Continue reading

See also:

Related medical questions

Drug information

Related support groups